British Business Bank backs Empirical Ventures with £15M to fund UK's venture scientists
What's the deal? The British Business Bank has committed a further £10 million to Empirical Ventures through itsRegional Angels ProgrammeDealroom has a profile for this one. Try Dealroom →, bringing its total support for the fund to £15 million. Empirical is a UK deeptech fund built around what it calls the "venture scientist" thesis: the idea that the most valuable companies of the coming decades will be founded by deep domain experts — scientists who can bridge fundamental research and commercial reality — rather than generalist entrepreneurs.
The additional capital will allow Empirical to back science-led founders outside London, across fields including energy, advanced materials, and life sciences.
Why now? The commitment aligns with the UK government's 2026 Modern Industrial Strategy, which aims to unlock the commercial potential of the country's research base. Britain has world-class universities and a deep pool of scientific talent, but turning that into fundable companies has long been hampered by a gap between academic rigour and investor fluency. Empirical was built specifically to close that gap.
The Regional Angels Programme is also designed to direct capital away from London and toward underserved parts of the UK — Bristol, Manchester, Edinburgh — where scientific talent exists but early-stage funding does not.
What could go wrong? Deeptech investing is structurally difficult: longer development timelines, higher capital requirements, and less predictable commercial paths than software startups. Patient capital is essential, but it also means longer periods before investors see returns — a challenge for fund managers trying to raise follow-on vehicles.
The "venture scientist" thesis is compelling but unproven at scale. Empirical is a specialist fund with a focused mandate, and its success depends on identifying the right scientists, supporting them through commercialisation, and doing so consistently enough to generate the returns needed to justify the model.
The signal: Empirical's raise reflects a broader shift in how the UK is thinking about its scientific advantage. For years, deep research sat in universities while the commercial opportunity leaked abroad — to the US, to better-funded ecosystems. A growing number of funds and institutions are now trying to keep that value onshore by backing scientists earlier and more specifically. The British Business Bank's continued support for Empirical, combined with the government's industrial strategy, suggests this is now a deliberate policy priority, not just a funding trend. Whether it produces category-defining companies will take a decade to know — but the infrastructure is being put in place.
Source:
Empirical Ventures
British Business Bank
A.M.
